Clinical Trials Browser

OTHER × Has results × gp100 Melanoma Antigen × Clear all

NCT00960752 2021-08-13

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Phase 2 Completed

47 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Neoplasms

NCT00003224 2014-11-20

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1 Completed

22 enrolled 14 charts

Melanoma